A randomized, double-blind, placebo-controlled single-dose, multiple-dose escalation study and a food effects study were conducted to evaluate the safety, tolerability, pharmacokinetic characteristics, and food effects of ISM5411 in healthy Chinese subjects.
Latest Information Update: 30 Mar 2026
At a glance
- Drugs Garutadustat (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
- Sponsors InSilico Medicine
Most Recent Events
- 09 Jan 2025 New trial record